Atlas Trials

Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)

Clinical trial NCT04610567 · UNKNOWN

Trial details

NCT number
NCT04610567
Sponsor
University of Sao Paulo General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CoronavirusInflammationCovid19
Start date
2020-10-27
Primary completion
2021-03-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.